{"id":196774,"date":"2026-07-25T01:56:50","date_gmt":"2026-07-25T07:26:50","guid":{"rendered":"https:\/\/newslink360.space\/?p=196774"},"modified":"2026-07-25T01:56:50","modified_gmt":"2026-07-25T07:26:50","slug":"first-human-receives-experimental-vaccine-against-rare-ebola-strain","status":"publish","type":"post","link":"https:\/\/newslink360.space\/?p=196774","title":{"rendered":"First Human Receives Experimental Vaccine Against Rare Ebola Strain"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n            <!-- image --><\/p>\n<div class=\"td-post-featured-image\"><a href=\"https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain.jpg\" data-caption=\"\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" width=\"696\" height=\"392\" class=\"entry-thumb td-modal-image lazyload\" src=\"https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-696x392.jpg\" srcset=\"https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-696x392.jpg 696w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-300x169.jpg 300w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-1024x576.jpg 1024w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-768x432.jpg 768w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-1068x601.jpg 1068w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain-746x420.jpg 746w, https:\/\/theindianpractitioner.com\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain.jpg 1244w\" data-sizes=\"(max-width: 696px) 100vw, 696px\" alt=\"\" title=\"Young Asia lady nurse giving Covid-19 or flu antivirus vaccine s\" style=\"--smush-placeholder-width: 696px; --smush-placeholder-aspect-ratio: 696\/392;\"\/><\/a><\/div>\n<p>            <!-- content --><\/p>\n<p style=\"text-align: justify;\"><strong>Oxford Launches First Human Trial<\/strong><\/p>\n<p style=\"text-align: justify;\">Researchers at the University of Oxford have administered the first dose of an experimental vaccine designed to protect against the Bundibugyo strain of Ebola, marking the world\u2019s first human trial for a vaccine targeting this rare but deadly virus. The Phase I clinical trial, named BD-Ebov, will enroll 50 healthy adults aged 18 to 55 to evaluate the vaccine\u2019s safety and its ability to trigger an immune response.<\/p>\n<p style=\"text-align: justify;\"><strong>Filling a Critical Gap<\/strong><\/p>\n<p style=\"text-align: justify;\">The Bundibugyo strain has caused multiple Ebola outbreaks in Africa, including the ongoing outbreak in the Democratic Republic of Congo and Uganda. However, unlike the Zaire strain\u2014which already has approved vaccines\u2014there is currently no licensed vaccine or specific treatment for Bundibugyo Ebola. As per BBC News, scientists accelerated the vaccine\u2019s development to address this critical gap and improve preparedness for future outbreaks.<\/p>\n<p style=\"text-align: justify;\"><strong>Why the Trial Matters<\/strong><\/p>\n<p style=\"text-align: justify;\">The vaccine uses Oxford\u2019s ChAdOx1 viral vector platform, which has previously been used in vaccines against other infectious diseases. If the trial demonstrates that the vaccine is safe and produces a strong immune response, researchers will move to larger studies to confirm its effectiveness. Although the process will take time, the trial represents an important step toward expanding protection against multiple Ebola strains.<\/p>\n<p style=\"text-align: justify;\"><strong>Growing Need for Better Protection<\/strong><\/p>\n<p style=\"text-align: justify;\">Meanwhile, health officials continue to battle one of the largest Bundibugyo Ebola outbreaks on record. The outbreak has claimed more than 1,000 lives and infected thousands of people, while conflict, misinformation, and limited healthcare resources have complicated response efforts. Therefore, experts believe a successful vaccine could significantly strengthen global efforts to contain future outbreaks and protect vulnerable communities.<\/p>\n<\/p><\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/theindianpractitioner.com\/first-human-receives-experimental-vaccine-against-rare-ebola-strain\/\" target=\"_blank\" rel=\"noopener\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Oxford Launches First Human Trial Researchers at the University of Oxford have administered the first dose of an experimental vaccine designed to protect against the Bundibugyo strain of Ebola, marking the world\u2019s first human trial for a vaccine targeting this rare but deadly virus. The Phase I clinical trial, named BD-Ebov, will enroll 50 healthy&#8230;<\/p>\n","protected":false},"author":1,"featured_media":196775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-196774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/newslink360.space\/wp-content\/uploads\/2026\/07\/First-Human-Receives-Experimental-Vaccine-Against-Rare-Ebola-Strain.jpg","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":193577,"url":"https:\/\/newslink360.space\/?p=193577","url_meta":{"origin":196774,"position":0},"title":"Confirmed Ebola cases top 2,000 in Congo, including 754 deaths","author":"Ajay Kumar Verma","date":"July 15, 2026","format":false,"excerpt":"Confirmed Ebola cases top 2,000 in Congo, including 754 deathsBUNIA, Congo \u2014Confirmed cases of Ebola in Congo have reached 2,011, including 754 deaths, according to government data released overnight in what authorities say is the fastest-growing outbreak on record even as some health workers have gone on strike over payment\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/624ed286-0d24-45bc-865b-fd79eb2953ac.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/624ed286-0d24-45bc-865b-fd79eb2953ac.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/624ed286-0d24-45bc-865b-fd79eb2953ac.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/624ed286-0d24-45bc-865b-fd79eb2953ac.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":196115,"url":"https:\/\/newslink360.space\/?p=196115","url_meta":{"origin":196774,"position":1},"title":"This year\u2019s Ebola outbreak has spread faster than the worst on record","author":"Ajay Kumar Verma","date":"July 23, 2026","format":false,"excerpt":"ABUJA, Nigeria -- ABUJA, Nigeria (AP) \u2014 The Ebola outbreak in Congo has killed over 1,000 people, reaching the grim milestone nearly three times faster than the 2014-2016 Ebola epidemic that is considered the worst on record.Data from Congo\u2019s Ministry of Health shows that as of Tuesday, the current outbreak,\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/wirestory_3fd6e1785afac22bb848dbc39f52a77b_16x9.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":196716,"url":"https:\/\/newslink360.space\/?p=196716","url_meta":{"origin":196774,"position":2},"title":"India&#8217;s First Dengue Vaccine Is Here: Who Should Get It And What You Need To Know","author":"Ajay Kumar Verma","date":"July 24, 2026","format":false,"excerpt":"India has approved its first dengue vaccine, marking a significant milestone in the country's efforts to combat one of its most persistent mosquito-borne diseases. The Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for Qdenga, a live, attenuated tetravalent dengue vaccine, making it the first vaccine approved in\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/imresizer-pexels-jorgemendoza80-9344579_20260725093022_ogImage_47.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/imresizer-pexels-jorgemendoza80-9344579_20260725093022_ogImage_47.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/imresizer-pexels-jorgemendoza80-9344579_20260725093022_ogImage_47.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/imresizer-pexels-jorgemendoza80-9344579_20260725093022_ogImage_47.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":195070,"url":"https:\/\/newslink360.space\/?p=195070","url_meta":{"origin":196774,"position":3},"title":"India approves first dengue vaccine for people aged 4-60 years \u2013 Asia News Network","author":"Ajay Kumar Verma","date":"July 20, 2026","format":false,"excerpt":"July 21, 2026 NEW DELHI \u2013 In a major breakthrough, India has approved its first dengue vaccine, with the Drug Controller General of India (DCGI) granting market authorisation to QDENGA from Takeda Biopharmaceuticals India. The vaccine was approved for individuals aged between 4 and 60 years. It can be administered\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AFP__20260227__94FG9WK__v1__MidRes__IndiaHealthVaccinesDengue.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AFP__20260227__94FG9WK__v1__MidRes__IndiaHealthVaccinesDengue.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AFP__20260227__94FG9WK__v1__MidRes__IndiaHealthVaccinesDengue.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AFP__20260227__94FG9WK__v1__MidRes__IndiaHealthVaccinesDengue.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AFP__20260227__94FG9WK__v1__MidRes__IndiaHealthVaccinesDengue.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":196237,"url":"https:\/\/newslink360.space\/?p=196237","url_meta":{"origin":196774,"position":4},"title":"\u2018There\u2019s no salary\u2019: DRC health workers tell of hardship as Ebola spreads | Ebola News","author":"Ajay Kumar Verma","date":"July 23, 2026","format":false,"excerpt":"Bunia, Democratic Republic of the Congo: The warning from the World Health Organization (WHO) is dire: The current outbreak of the Ebola virus currently spreading in the eastern Democratic Republic of the Congo (DRC) might be one of the world\u2019s worst, the agency has said over and over. In the\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/AP26177436023175-1784480842.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":193653,"url":"https:\/\/newslink360.space\/?p=193653","url_meta":{"origin":196774,"position":5},"title":"Childhood Vaccination Coverage Improves Worldwide, but Challenges Persist \u2013 UNICEF, WHO","author":"Ajay Kumar Verma","date":"July 15, 2026","format":false,"excerpt":"Childhood immunization coverage has shown gradual improvement worldwide despite ongoing conflicts, vaccine hesitancy, and health system challenges. In 2025, around 90% of infants globally received at least one dose of the diphtheria, tetanus, and pertussis (DTP) vaccine, while 85% completed the full three-dose series. However, global vaccination coverage remains slightly\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/WHO-logo-1-scaled.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnRh4-PbM","_links":{"self":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/196774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=196774"}],"version-history":[{"count":0,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/196774\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/media\/196775"}],"wp:attachment":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=196774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=196774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=196774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}